CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancerVenkatesh Rajamanickam, Kristina H. Young, Tomoko Yamazaki et al.|Translational Oncology|2026Cited by 0
Abstract LB425: Search for targets of anti-cancer immunity in patients receiving an off-the-shelf cancer’s dark matter vaccine, DPV-001, combined with anti-PD-1 +/- anti-GITR in head and neck squamous cell cancer (HNSCC)Traci Hilton, Bernard A. Fox, Ryan Meng et al.|Cancer Research|2026Cited by 0